10 Year Financial Data of Idexx Laboratories (IDXX)

83.81 (1y: -4%)

Market Cap	4.57 B	P/E(ttm)	25.70
Enterprise Value	4.6 B	P/B	7.19

IDXX- NAS (USA)
Idexx Laboratories

Currently 4.5/5

Business Predictability Rank: 4.5-Star
Back Testing Results:
Average gain of all 4.5-Star stocks: 10.6% per year.
% of Stocks that are in still loss if held for 10yrs: 10%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$83.81

1 Medium Warning Sign 6 Good Signs

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	15	9.2	7.3
EBITDA Growth (%)	16.3	12.6	11.4
Free Cash Flow Growth (%)	13.4	37.8	4.8
Book Value Growth (%)	8.6	11	13.3

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue per Share ($)	6.62	7.67	9.37	11.21	14.31	16.45	17.00	18.53	20.93	23.03	23.30	5.72	5.97	5.62	5.73	5.98
EBITDA per Share	1.38	1.77	2.05	2.39	2.75	3.55	3.72	4.19	4.89	5.61	5.67	1.30	1.58	1.35	1.39	1.35
Free Cashflow per Share	1.40	0.89	1.36	0.58	1.07	0.72	1.91	2.34	2.87	2.92	2.84	0.09	0.87	0.99	0.98	--
Earnings per Share ($)	0.80	1.10	1.15	1.42	1.46	1.87	2.01	2.37	2.78	3.17	3.26	0.72	0.91	0.76	0.78	0.81
Book Value per Share	5.75	5.55	5.42	6.22	6.80	7.04	8.48	9.64	9.27	11.33	11.38	10.04	10.49	11.01	11.40	11.38
Month End Stock Price	23.14	27.30	35.99	39.65	58.63	36.08	53.45	69.22	76.96	92.80	92.39	87.45	96.13	99.35	92.80	92.39
Ratios	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Return on Equity %	13.80	19.70	21.20	22.90	21.40	26.50	23.80	24.60	30.00	28.00	28.40	28.80	34.80	27.60	27.20	28.40
Return on Assets %	10.90	15.20	15.90	16.70	13.40	15.20	15.10	15.70	15.70	16.20	16.00	15.20	19.20	15.60	15.60	16.00
Return on Capital - Joel Greenblatt %	84.70	84.20	91.40	70.60	57.50	53.40	52.90	58.20	64.90	66.10	55.60	61.20	76.00	63.20	64.00	55.60
Debt to Equity	0.00	0.00	0.00	0.02	0.18	0.36	0.24	0.23	0.46	0.34	0.42	0.45	0.42	0.38	0.34	0.42

Gross Margin %	48.40	50.80	50.60	51.30	50.20	51.70	51.00	52.40	53.00	54.10	55.40	54.20	55.00	54.10	52.90	55.40
Operating Margin %	16.90	19.70	18.10	17.30	14.80	16.80	17.10	18.50	19.40	20.30	18.40	18.70	22.60	19.90	19.80	18.40
Net Margin %	12.00	14.30	12.30	12.70	10.20	11.30	11.80	12.80	13.30	13.80	13.50	12.60	15.30	13.60	13.60	13.50

Days Sales Outstanding	41.40	43.60	41.00	40.20	42.90	39.70	40.70	39.70	42.30	39.00	43.60	45.40	39.90	40.80	39.40	43.60
Days Inventory	112	103	80.30	97.40	78.60	85.60	79.80	88.90	84.90	86.60	91.10	86.80	86.60	92.70	85.20	91.10
Inventory Turnover	3.30	3.50	4.50	3.70	4.60	4.30	4.60	4.10	4.30	4.20	1.00	1.00	1.10	1.00	1.10	1.00

Debt to Revenue	0.00	0.00	0.00	0.01	0.09	0.15	0.12	0.12	0.20	0.17	0.79	0.80	0.74	0.74	0.67	0.79
COGS to Revenue	0.52	0.49	0.49	0.49	0.50	0.48	0.49	0.48	0.47	0.46	0.45	0.46	0.45	0.46	0.47	0.45
Inventory to Revenue	0.16	0.14	0.11	0.13	0.11	0.11	0.11	0.12	0.11	0.11	0.45	0.44	0.43	0.47	0.44	0.45
Interest Exp. to Revenue %	0.60	0.56	0.49	0.38	-0.15	-0.22	-0.14	-0.16	-0.15	-0.15	-0.12	-0.24	-0.13	-0.13	-0.11	-0.12

Asset Turnover	0.91	1.07	1.30	1.32	1.31	1.34	1.28	1.23	1.18	1.17	0.29	0.30	0.31	0.29	0.29	0.29
Buyback Ratio	-54.60	-24.70	-24.10	-22.30	-22.30	--	--	--	--	--	--	--	--	--	--	--
Income Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Revenue	476	549	638	739	923	1,024	1,032	1,103	1,219	1,293	1,303	323	336	315	320	332
Cost of Goods Sold	246	270	315	360	459	494	505	525	572	594	594	148	151	145	150	148
Gross Profit	230	279	323	380	464	530	526	579	647	699	708	175	185	171	169	184

Selling, General, &Admin. Expense	118	136	167	198	260	287	285	306	334	355	362	93.81	88.81	87.37	84.57	101
Research &Development	32.32	35.40	40.95	53.62	67.34	70.67	65.12	68.60	76.04	82.01	83.22	20.56	20.06	20.35	21.05	21.76
Earnings Before DDA	99.28	126	140	158	177	221	226	250	284	315	317	73.11	88.80	75.71	77.35	74.70

Depreciation, Depletion and Amortization	18.90	18.43	24.37	29.82	41.10	48.82	49.77	45.96	48.20	52.41	53.22	12.71	12.99	12.80	13.92	13.51

Operating Income	80.39	108	115	128	136	172	176	204	236	263	263	60.41	75.82	62.91	63.43	61.19
Interest Income/Expense	2.87	3.07	3.14	2.82	-1.34	-2.27	-1.43	-1.75	-1.80	-1.95	-1.58	-0.76	-0.45	-0.40	-0.34	-0.39
Net Income	57.09	78.33	78.25	93.68	94.01	116	122	141	162	178	182	40.74	51.32	42.85	43.35	44.86

Earnings per Share ($)	0.80	1.10	1.15	1.42	1.46	1.87	2.01	2.37	2.78	3.17	3.26	0.72	0.91	0.76	0.78	0.81
Total Shares Outstanding	71.86	71.60	68.11	65.91	64.46	62.25	60.68	59.56	58.21	56.16	55.49	56.44	56.21	56.09	55.81	55.49
Balance Sheet	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Cash and cash equivalents	221	137	133	96.67	60.36	78.87	107	157	184	224	228	185	202	221	224	228
Accounts Receivable	53.98	65.64	71.69	81.39	108	111	115	120	141	138	159	161	147	141	138	159
Inventory	75.33	76.42	69.37	96.00	98.80	116	110	128	133	141	148	141	144	147	141	148
Other Current Assets	20.58	22.26	25.46	28.21	38.12	49.60	44.08	55.71	65.96	66.28	58.80	57.29	62.63	60.49	66.28	58.80
Total Current Assets	371	302	299	302	306	356	376	461	524	570	594	545	555	571	570	594

Property, Plant and Equipment	45.22	62.63	65.70	99.63	142	190	200	202	217	245	254	217	221	232	245	254
Intangible Assets	61.77	124	119	148	236	207	213	205	242	238	233	244	236	238	238	233
Other Long Term Assets	44.30	25.52	6.99	9.49	18.25	12.81	19.63	29.96	47.99	51.06	51.01	55.78	55.87	52.96	51.06	51.01
Total Assets	522	514	491	560	702	765	809	897	1,031	1,104	1,133	1,061	1,067	1,093	1,104	1,133

Accounts Payable	91.97	85.72	95.86	113	140	133	124	141	178	173	157	167	158	166	173	157
Current Portion of Long-Term Debt	0.49	1.29	0.55	0.68	72.96	151	120	130	244	213	261	255	245	233	213	261
Other Current Liabilities	8.28	12.94	10.16	10.76	10.68	11.29	12.61	13.98	15.03	20.19	21.27	15.65	16.02	16.49	20.19	21.27
Total Current Liabilities	101	99.95	107	125	223	295	256	285	437	406	440	437	419	416	406	440

Long-Term Debt	0.79	0.39	--	6.45	5.73	5.09	4.28	3.42	2.50	1.39	1.14	2.26	2.02	1.78	1.39	1.14
Other Long-Term Liabilities	7.06	16.23	15.10	18.51	34.74	26.86	33.37	34.38	51.86	59.65	60.67	54.68	56.21	58.22	59.65	60.67
Total Liabilities	109	117	122	150	264	327	294	323	491	467	501	494	477	476	467	501

Common Stock	4.44	4.52	4.59	4.66	9.45	9.54	--	9.80	9.92	10.02	10.06	9.96	9.97	9.99	10.02	10.06
Retained Earnings	240	319	397	491	586	702	824	966	1,127	1,306	1,350	1,168	1,219	1,262	1,306	1,350
Additional Paid-In Capital	383	411	437	480	515	549	581	642	703	757	779	717	727	742	757	779
Treasury Stock	-219	-348	-472	-578	-697	-830	-915	-1,061	-1,320	-1,457	-1,525	-1,352	-1,380	-1,416	-1,457	-1,525
Total Equity	413	398	369	410	438	438	515	574	540	636	631	567	590	618	636	631
Cashflow Statement	Annuals (USD $) View: $ %											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	TTM	Mar12	Jun12	Sep12	Dec12	Mar13

Net Income	57.09	78.33	78.25	93.68	94.01	116	122	141	162	178	182	40.73	51.32	42.87	43.36	44.87
Depreciation, Depletion and Amortization	18.90	18.43	24.37	29.82	41.10	48.82	49.77	45.96	48.20	52.41	53.22	12.71	12.99	12.80	13.92	13.51
Cash Flow from Others	41.17	-1.38	13.93	-13.67	0.01	-21.68	2.94	-8.44	10.74	-0.41	0.15	-38.26	-0.69	19.02	19.52	-37.70
Cash Flow from Operations	117	95.38	117	110	135	143	175	179	221	230	236	15.18	63.62	74.69	76.79	20.68

Investment for Property, Plant & Equipement	-16.90	-31.71	-24.20	-71.36	-66.24	-98.62	-59.08	-39.30	-53.46	-66.39	-76.47	-10.35	-14.86	-18.93	-22.26	-20.42
Cash Flow from Acquisitions	-2.30	-53.94	-10.22	--	-89.88	--	3.38	--	-43.76	0.34	0.84	3.00	--	--	-2.66	3.50
Cash Flow from Investing	-42.23	-36.75	12.59	-40.70	-121	-91.60	-53.62	-43.19	-97.00	-66.01	-75.58	-7.34	-14.81	-18.93	-24.92	-16.92

Net Issuance of Stock	-4.65	-110	-105	-84.79	-97.45	-132	-83.10	-143	-256	-132	-168	-27.63	-27.38	-36.15	-41.12	-63.78
Net Issuance of Debt	-0.51	-0.36	-2.06	-0.88	69.99	78.96	-33.76	9.33	113	-31.92	5.07	10.78	-10.23	-12.23	-20.24	47.76
Other Financing	--	-0.00	--	9.41	9.27	22.60	21.56	46.99	44.81	38.84	46.82	10.29	5.90	11.15	11.50	18.27
Cash Flow from Financing	-5.16	-110	-107	-76.26	-18.19	-30.79	-95.30	-86.77	-97.66	-125	-117	-6.56	-31.70	-37.23	-49.85	2.25

Net Change in Cash	72.93	-49.79	20.00	-5.49	-1.31	18.51	27.86	50.19	26.98	40.09	42.87	1.60	16.32	19.63	2.55	4.38

Free Cash Flow	100	63.67	92.35	38.47	68.88	44.69	116	140	167	164	159	4.84	48.76	55.76	54.53	0.26
Valuation Ratios (Daily)	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Quarterly
Fiscal Period	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Latest Q.	Mar12	Jun12	Sep12	Dec12	Mar13

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

IDXX Quarterly/Annuals Reports

IDXX: 10-Q - IDEXX LABORATORIES INC /DE (0000874716) (Filer): (10-Q) - 2012-07-20
IDXX: 10-Q - IDEXX LABORATORIES INC /DE (0000874716) (Filer): (10-Q) - 2012-04-20
IDXX: 10-K - IDEXX LABORATORIES INC /DE (0000874716) (Filer): (10-K) - 2012-02-17
IDXX: 10-Q - IDEXX LABORATORIES INC /DE (0000874716) (Filer): (10-Q) - 2011-10-21
IDXX: 10-Q - IDEXX LABORATORIES INC /DE (0000874716) (Filer): (10-Q) - 2011-07-22

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

IDXX Quarterly/Annuals Reports